Medications like lecanemab (Leqembi) and donanemab (Kisunla) target amyloid plaques in the brain that build up due to Alzheimer’s disease. They may help slow disease progression for people in ...

Reviewed By Anton Porsteinsson, MD, Director of the University of Rochester Alzheimer’s Disease Care, Research and Education Program (AD-CARE) in New York; and the first William B. and Sheila ...

Reviewed By Anton Porsteinsson, MD, Director of the University of Rochester Alzheimer’s Disease Care, Research and Education Program (AD-CARE) in New York; and the first William B. and Sheila ...

Lucía Chávez Gutiérrez (VIB-KU Leuven) has unraveled the genetic contributions to familial Alzheimer's Disease development and revealed how specific mutations act as a clock to predict the ...

A previously recognized biomarker for Alzheimer’s, is now confirmed as a causal factor for the disease, with the help of AI. About one in nine people aged 65 and older has Alzheimer’s disease ...

friends and partners to create a special Mother’s Day for those living with Alzheimer’s disease or a related dementia. According to the Alzheimer’s Foundation of America, people should use ...

Most Americans want to know if they're destined to lose their brain power to Alzheimer's disease, according to an annual report produced by the Alzheimer's Association. About 4 out of 5 Americans ...

South Carolina families wondering if a loved one has Alzheimer's disease or other dementias might soon have access to a blood test that could give them some answers. A statewide consortium is also ...

CLEVELAND, Ohio -- For the first time, the number of Americans living with Alzheimer’s disease is more than 7 million, and deaths due to the illness are increasing, according to a new report.

More than half a million people in Florida over the age of 65 — 557,084 — suffered from Alzheimer’s disease in 2024. The CDC estimated the number of people living with Alzheimer's is ...

Alzheimer’s disease now affects more than seven million people in the U.S., and nearly four in five Americans say they would want to know if they have it before symptoms emerge. This data comes ...